Additionally, a recent study indicated that in obese patients and those with established cardiovascular disease (CVD), once-weekly semaglutide injections were associated with a reduced risk of major adverse cardiac events, including death, nonfatal heart attack, and stroke
The 15-year journey from a $20 million government grant to a clinically-validated product that's now positioned as both alternative and adjunct to GLP-1 injectables demonstrates what's possible when research meets real-world commercial considerations from day one
Ongoing support and follow-up care can help patients stay focused on their goals and maintain the progress they have achieved
Other versions of the drug are Rybelsus (oral) and Wegovy (injectable) (11)
Semaglutide is sensitive to heat, not cold, so winter deliveries in Michigan are generally low-risk
In animal models, RvD1 markedly reduced the pulmonary bacterial burden and neutrophil infiltration in mice with chronic Pseudomonas infection [193]